New 2025 Menopause Guidelines: What Every Woman Needs to Know

madman · May 2, 2025

Dr. Kelly Casperson joins forces with Dr. Rachel Rubin to unpack the groundbreaking 2025 Genitourinary Syndrome of Menopause guidelines from the American Urologic Association.

From the safety and importance of vaginal hormones to the critical need for shared decision-making and advocacy, this conversation is a must-watch for healthcare providers and anyone passionate about women’s health.

Topics include:

* Why less than 4% of women are getting hormone therapy

* How these guidelines could transform care and save healthcare costs

* The marketing problem in women’s healthMaking education and resources accessible for all

Chapters

00:00 Introduction to the New Guidelines
02:12 The Multidisciplinary Approach to Guidelines
04:43 Shared Decision Making in Women's Health
07:12 The Importance of Vaginal Hormones
09:41 Access to Guidelines and Resources
12:32 The Role of Advocacy in Women's Health
15:21 The Need for Comprehensive Care
18:10 Economic Implications of Vaginal Estrogen
21:34 Understanding Genitourinary Syndrome of Menopause
24:23 The Marketing Challenge of Women's Health
27:46 The Future of Women's Health Guidelines'

madman · May 3, 2025

Thread 'Advancing sexual health in urology'

May 3, 2025

* Rubin offers insight into the guideline development process, which involved collaboration across multiple societies—including AUA, SUFU, AUGS, the Menopause Society, and ISSWSH—and incorporated patient perspectives alongside clinical evidence. The guidelines advocate for broader recognition of GSM as a urologic issue with systemic impact, including increased risk of recurrent UTIs, sepsis, and hospitalizations. Rubin underscores the evidence linking vaginal estrogen therapy to improved outcomes and reduced Medicare costs, pushing back on long-standing misconceptions about hormone...

madman · Jun 2, 2025

Thread 'New GSM Guidelines Every Physician Should Know'

Jun 2, 2025

In this episode of the You Are Not Broken podcast, I dive into the new clinical guidelines for Genitourinary Syndrome of Menopause (GSM)—because you deserve facts, not fear.

We cover:

-- Why education around midlife hormonal changes isn’t optional
-- The role of pelvic exams (and how to make them less intimidating)
-- Non-hormonal treatments that actually work
-- Why GSM impacts more than you think your comfort, intimacy, and overall health

This episode is your call to action. Use these new guidelines to spark real conversations...

madman · Jul 29, 2025

Thread 'Why Low-Dose Vaginal Estrogen is Safe: Debunking Menopause Myths and Fighting for Women's Health'

Jul 29, 2025

Is one outdated warning label standing between millions of women and safe, effective care? In this episode of BackTable Urology, Dr. Yahir Santiago-Lastra, a urologist specializing in female pelvic medicine and reconstructive surgery at UC San Diego, joins host Dr. Suzette Sutherland to discuss the black box warning on vaginal estrogen, its historical context, and the ongoing advocacy efforts to update outdated FDA guidelines.

SYNPOSIS

The conversation covers the importance of low-dose vaginal estrogen in treating genitourinary syndrome of...

madman · 2025-08-15T10:45:13-0500

Thread 'Genitourinary Syndrome of Menopause (GSM): Latest Guidelines, Treatments & Myths Debunked'

Today at 10:44 AM

The guidelines are in and the myths are out. In this episode of the BackTable Podcast, Dr. Suzette Sutherland hosts Dr. Melissa Kaufman and Dr. Giulia Ippolito to discuss the new 2025 AUA/SUFU guidelines on genitourinary syndrome of menopause (GSM).

===========
SYNPOSIS

The doctors delve into what GSM is, its symptoms, and the new evidence-based clinical guidelines for screening, diagnosing, and treating this condition. The episode emphasizes shared decision-making, safe use of local low-dose vaginal estrogen, and addresses...